---
title: "This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283521314.md"
description: "Wall Street analysts have downgraded Mohawk Industries from Outperform to Neutral, reducing the price target from $156 to $118, with shares closing at $109.51. Additionally, Passage Bio was downgraded from Outperform to Neutral, with a price target cut from $32 to $8, closing at $6.25. These changes reflect a shift in analyst outlook for these companies."
datetime: "2026-04-21T14:30:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283521314.md)
  - [en](https://longbridge.com/en/news/283521314.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283521314.md)
---

# This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Baird analyst Timothy Wojs downgraded **Mohawk Industries Inc** (NYSE:MHK) from Outperform to Neutral and cut the price target from $156 to $118. Mohawk Industries shares closed at $109.51 on Monday. See how other analysts view this stock.
-   Wedbush analyst Yun Zhong downgraded **Passage Bio, Inc.** (NASDAQ:PASG) from Outperform to Neutral and lowered the price target from $32 to $8. Passage Bio shares closed at $6.25 on Monday. See how other analysts view this stock.

Considering buying MHK stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [PASG.US](https://longbridge.com/en/quote/PASG.US.md)
- [MHK.US](https://longbridge.com/en/quote/MHK.US.md)
- [XLB.US](https://longbridge.com/en/quote/XLB.US.md)

## Related News & Research

- [Mohawk shareholders approve 2026 incentive plan reserving 3,500,000 shares](https://longbridge.com/en/news/287268032.md)
- [Mohawk Establishes New $1.5 Billion Revolving Credit Facility](https://longbridge.com/en/news/286325025.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)